MSB 3.76% $1.03 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-187

  1. 457 Posts.
    lightbulb Created with Sketch. 265
    For all those people that questioned the use of placebo in the Covid-19 trial - this is the reason - to stop people questioning the science, sewing seeds of doubt. It is sad that people need to die to prove effectiveness, but it is better than hundreds of thousands dying if the product is not approved.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.